Advertisement

Topics

Intercept Pharma Release: CONTROL Trial Shows Statin Therapy Reversed LDL Increases To Below Baseline Levels In NASH Patients Treated With OCA

20:00 EDT 30 Jul 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Intercept Pharma Release: CONTROL Trial Shows Statin Therapy Reversed LDL Increases To Below Baseline Levels In NASH Patients Treated With OCA

NEXT ARTICLE

More From BioPortfolio on "Intercept Pharma Release: CONTROL Trial Shows Statin Therapy Reversed LDL Increases To Below Baseline Levels In NASH Patients Treated With OCA"

Quick Search
Advertisement